03353nam 2200553 450 991078770270332120230803195437.03-95489-698-2(CKB)2670000000534309(EBL)1640301(SSID)ssj0001215256(PQKBManifestationID)11772711(PQKBTitleCode)TC0001215256(PQKBWorkID)11191720(PQKB)10652893(MiAaPQ)EBC1640301(Au-PeEL)EBL1640301(CaPaEBR)ebr10856464(OCoLC)871779539(EXLCZ)99267000000053430920140415h20142014 uy 0engur|n|---|||||txtccrCRO- contract research organization how drug research is evolving /Jakob MieraHamburg, Germany :Anchor Academic Publishing,2014.©20141 online resource (91 p.)Description based upon print version of record.3-95489-198-0 Includes bibliographical references.CRO - Contract Research Organization; Index; List of Figures; List of Tables; List of Abbreviations; Introduction; Methodology; 1. Merger & Acquisitions Fundamentals; 1.1 Definition and History; 1.2 Types and history of Merger & Acquisitions; 1.3 Recent M&A Trends; 2. Contract Research Organization Industry; 2.1 The Drug Development Process; 2.2 Fundamentals of Contract Research Organizations; 2.3 Strategic Analysis of the Drug Development Market; 2.4 Growth Strategies in CRO Industry; 3. Explanatory Approaches and Motives for M&A; 3.1 Strategic Motives; 3.2 Financial Motives3.3 Managerial Motives4. Success Factors for the Merger & Acquisitions process; 4.1 Merger & Acquisitions Process; 4.2 Potential Success Factors during the M&A process; 5. Case Study: Merger & Acquisitions in the CRO industry; 5.1 Data & Methodology; 5.2 Why M&A occur in the CRO Industry; 5.3 Potential Success Factors for the M&A process in the CRO industry; 5.4 Reasons for success failures for the M&A process in the CRO industry; 5.5 Determinants and evaluation for success after the M&A; 6. Conclusion and Recommendations; Appendix; BibliographyThis book deals in general with mergers and acquisitions in the CRO industry, and more specifically with reasons for M and A, success factors during the M and A process, and why M and A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than 800 million and lasting between 10 and 15 years. Due to these Pharmaceutical biotechnologyGermanyBiopharmaceuticsEconomic aspectsPharmaceutical biotechnologyBiopharmaceuticsEconomic aspects.615.19Miera Jakob1476313MiAaPQMiAaPQMiAaPQBOOK9910787702703321CRO- contract research organization3690888UNINA